5.10% p.a. Early Redemption Worst of GOAL

Underlying: Biogen Idec / Novo Nordisk / Takeda Pharmaceutical SSPA/EUSIPA Product Type: Reverse Convertibles (1220) Valor: 41051278 / ISIN: CH0410512781

Last update 17:35:33
  • Bid

    101.18 %
    Volume: 10'000

  • Ask

    102.18 %
    Volume: 10'000

  • "Worst of" View
Important note: The price data of the underlying asset that are displayed here merely serve as an indication and may not necessarily correspond to the prices that are relevant for the repayment or for any thresholds such as a stop-loss event or a knockout event. Only the sources and reference prices specified in the legally binding product documentation are relevant.

Takeda Pharmaceutical

NameTakeda Pharmaceutical
Valor763546
ISINJP3463000004
Reuters4502.T
Day high4'437.00 JPY
Day low4'437.00 JPY
Previous close--
52 Week high--
52 Week low--

Novo Nordisk

NameNovo Nordisk
Valor23159222
ISINDK0060534915
ReutersNVOb.VX
Day high--
Day low--
Previous close--
52 Week high--
52 Week low--

Biogen Idec

NameBiogen Idec
Valor1720684
ISINUS09062X1037
ReutersBIIB.O
Day high340.50 USD
Day low334.94 USD
Previous close338.34 USD
52 Week high388.67 USD
52 Week low249.24 USD